In a recent study, men showed higher TSPO binding on PET compared to women, both in MS and healthy individuals, and this sex difference in TSPO-expressing microglia was suggested to contribute to the higher likelihood of progression in men with MS (66). Here, TSPO is linked to myeloid sarcoma.